E. Hopp

866 total citations
7 papers, 512 citations indexed

About

E. Hopp is a scholar working on Cellular and Molecular Neuroscience, Ecology, Evolution, Behavior and Systematics and Molecular Biology. According to data from OpenAlex, E. Hopp has authored 7 papers receiving a total of 512 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Cellular and Molecular Neuroscience, 2 papers in Ecology, Evolution, Behavior and Systematics and 1 paper in Molecular Biology. Recurrent topics in E. Hopp's work include Neurobiology and Insect Physiology Research (2 papers), Photoreceptor and optogenetics research (1 paper) and Retinal Development and Disorders (1 paper). E. Hopp is often cited by papers focused on Neurobiology and Insect Physiology Research (2 papers), Photoreceptor and optogenetics research (1 paper) and Retinal Development and Disorders (1 paper). E. Hopp collaborates with scholars based in United States, Germany and Austria. E. Hopp's co-authors include Mark Mazurek, Roozbeh Kiani, Michael N. Shadlen, Timothy D. Hanks, Alexander Borst, Juergen Haag, Georg Ammer, Tabea Schilling, Aljoscha Nern and Étienne Serbe and has published in prestigious journals such as Nature, Journal of Neuroscience and Annals of Oncology.

In The Last Decade

E. Hopp

7 papers receiving 508 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
E. Hopp United States	4	276	251	103	80	60	7	512
Benjamin B. Scott United States	12	270 1.0×	171 0.7×	198 1.9×	103 1.3×	162 2.7×	22	715
Mamiko Niwa United States	12	407 1.5×	130 0.5×	55 0.5×	50 0.6×	59 1.0×	18	585
Ahmed El Hady United States	10	147 0.5×	145 0.6×	81 0.8×	41 0.5×	15 0.3×	16	418
Sara Ann Haddad United States	7	135 0.5×	185 0.7×	63 0.6×	24 0.3×	14 0.2×	7	324
Alexander Vaughan United States	8	130 0.5×	297 1.2×	212 2.1×	194 2.4×	252 4.2×	9	654
Kit D. Longden United Kingdom	10	142 0.5×	236 0.9×	65 0.6×	128 1.6×	110 1.8×	17	382
Adam J. Calhoun United States	8	147 0.5×	109 0.4×	38 0.4×	74 0.9×	52 0.9×	10	372
Tarciso Velho United States	14	256 0.9×	202 0.8×	135 1.3×	292 3.6×	76 1.3×	22	777
Rava Azeredo da Silveira United States	14	395 1.4×	439 1.7×	416 4.0×	18 0.2×	6 0.1×	30	742
Lyubov Ushakova Austria	10	236 0.9×	175 0.7×	74 0.7×	33 0.4×	20 0.3×	13	477

Countries citing papers authored by E. Hopp

Since Specialization

Citations

This map shows the geographic impact of E. Hopp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Hopp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Hopp more than expected).

Fields of papers citing papers by E. Hopp

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Hopp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Hopp. The network helps show where E. Hopp may publish in the future.

Co-authorship network of co-authors of E. Hopp

This figure shows the co-authorship network connecting the top 25 collaborators of E. Hopp. A scholar is included among the top collaborators of E. Hopp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Hopp. E. Hopp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Lee, Jang‐Ming, Austin Miller, Peter G. Rose, et al.. (2023). 746MO Randomized phase II trial of durvalumab in combination with olaparib and cediranib (DOC) compared to olaparib and cediranib (OC) or durvalumab and cediranib (DC) or standard of care chemotherapy (SOC) in platinum-resistant ovarian cancer with prior bevacizumab (NRG-GY023). Annals of Oncology. 34. S511–S511. 2 indexed citations

2.

Jackson, Christian, et al.. (2019). The ovarian cancer message isn’t getting out: Using Google search data to gauge ovarian cancer awareness. Gynecologic Oncology. 154. 130–131. 1 indexed citations

3.

Hopp, E., Alexander Borst, & Juergen Haag. (2014). Subcellular mapping of dendritic activity in optic flow processing neurons. Journal of Comparative Physiology A. 200(5). 359–370. 17 indexed citations

4.

Hopp, E., et al.. (2014). Computation of visual information in the dendritic trees of the fly. Max Planck Digital Library. 1 indexed citations

5.

Haag, Juergen, Georg Ammer, Étienne Serbe, et al.. (2013). A directional tuning map of Drosophila elementary motion detectors. Nature. 500(7461). 212–216. 237 indexed citations

6.

Hanks, Timothy D., Mark Mazurek, Roozbeh Kiani, E. Hopp, & Michael N. Shadlen. (2011). Elapsed Decision Time Affects the Weighting of Prior Probability in a Perceptual Decision Task. Journal of Neuroscience. 31(17). 6339–6352. 236 indexed citations

7.

Fagiuoli, S., et al.. (1994). Rheumatoid arthritis: a complication of interferon therapy.. BOA (University of Milano-Bicocca). 87(5). 228–30. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact